Company news
Sharp Therapeutics Corp. news in 2026
Sharp Therapeutics Corp.'s news releases, calls and decks from 2026, newest first.
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
August 28, 2026
Sharp Therapeutics Announces Closing of Non-Brokered Private Placement
July 29, 2026
Sharp Therapeutics Announces Non-Brokered Private Placement and Provides Operational Update
July 15, 2026
Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date
June 30, 2026
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C
May 28, 2026
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 17, 2026
Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs
April 10, 2026
Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering
April 10, 2026
Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering
April 2, 2026
Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering
March 13, 2026
Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering
February 27, 2026
Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes
February 2, 2026
Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board
January 27, 2026